Literature DB >> 16177012

Technical note: evaluation of dosimetric performance in a commercial 3D treatment planning system.

P Sandilos1, S Seferlis, C Antypas, P Karaiskos, C Dardoufas, L Vlahos.   

Abstract

The aim of this work was to evaluate the dosimetric performance of a commercial treatment planning system (TPS) which employs a three-dimensional calculation algorithm (Nucletron Plato version 2.2.3), following the guidelines of the AAPM Task Group 23 (TG23). Seven test cases were used to test the TPS dosimetric performance in homogeneous water. These cases involved absolute dose measurements on central as well as off-axis points situated at various depths, using simple field arrangements, and comparison with corresponding TPS calculations. This comparison yielded differences within +/-2% at all points, for all test cases. To test the ability of the TPS to account for tissue inhomogeneities, corresponding comparisons were performed with the presence of a low-density material in the beam to resemble an air inhomogeneity. Absolute dose measurements and corresponding TPS calculations showed a mean deviation of the order of +/-3.5%, reaching a maximum of 11.5% for small field sizes (5 cm x 5 cm). In summary, observed deviations are well within the set tolerance levels while comparison with previous TPS versions showed that Plato version 2.2.3 is significantly improved, especially in dose calculations in the presence of low density inhomogeneities.

Entities:  

Mesh:

Year:  2005        PMID: 16177012     DOI: 10.1259/bjr/57562962

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  2 in total

1.  Dosimetric evaluation of a three-dimensional treatment planning system.

Authors:  Appasamy Murugan; Xavier Sidonia Valas; Kuppusamy Thayalan; Velayudham Ramasubramanian
Journal:  J Med Phys       Date:  2011-01

2.  Experimental validation of the Eclipse AAA algorithm.

Authors:  Karen Breitman; Satyapal Rathee; Chris Newcomb; Brad Murray; Donald Robinson; Colin Field; Heather Warkentin; Sherry Connors; Marc Mackenzie; Peter Dunscombe; Gino Fallone
Journal:  J Appl Clin Med Phys       Date:  2007-05-10       Impact factor: 2.102

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.